ESCRS - Increasing predictability

Increasing predictability

Trifocal IOL yields good results in eyes that have had previous laser ablation

Increasing predictability
Roibeard O’hEineachain
Roibeard O’hEineachain
Published: Monday, April 1, 2019
[caption id="attachment_14477" align="alignleft" width="1024"] Spherical equivalent refraction accuracy[/caption] Optimised IOL calculations can further improve the refractive predictability of the FineVision trifocal IOL in presbyopic patients who have previously undergone excimer laser corneal refractive surgery, Luis Brenner MD told the 36th Congress of the ESCRS in Vienna, Austria.
Luis Brenner MD
Dr Brenner, Oslo, Norway, presented the results of a multi-centre retrospective single protocol study involving 241 eyes of 123 patients who had undergone previous PRK, LASIK or LASEK and underwent presbyopic RLE with FineVision trifocal lens implantation during the years 2015-2017 at Memira Clinics in Scandinavia. The results showed that 85% of patients achieved binocular uncorrected distance and near visual acuities of 0.9 and J3, respectively. In addition, 80.9% were within 0.5D of predicted postoperative refraction and 97.9% of eyes were within 1.0D at the three months, Dr Brenner said. Dr Brenner noted that from 2016 they included IOL constant optimisation and a nomogram to correct for prediction errors to the online ASCRS IOL calculator. They found that the mean refractive error was -0.29D for the standard calculation group compared to only -0.14D for the optimised calculation group. In addition, only 76% of eyes were within 0.5D of target refraction in the standard calculation group, compared to 84% of the eyes in the optimised group. PREVIOUS ABLATIONS The study included 155 eyes (64.3%) that had undergone previous myopic ablations. Among those with prior refractive data, the mean manifest refraction spherical equivalent (MRSE) was -3.05D (range: -0.75 to -7.00D). Also included were 86 eyes (35.7%) that had undergone hyperopic ablations. Among those with previous data, the mean MRSE was +1.99 to 0.84D (range: 0.00 to +4.00D). All eyes in the study were presbyopic to the point that a 1.50D add for near vision tasks was required. The study’s exclusion criteria were abnormal optics determined by topography, de-centred ablations, high ametropic ablations and corrected distance visual acuity of less than 0.8. Prior to implantation of the trifocal IOL, the myopic ablation group had a Snellen corrected distance visual acuity CDVA of 1.09, an uncorrected near visual acuity (UNVA, American point type) of 12.42 and an MRSE of -0.06. Following implantation of the IOL, the group had mean Snellen uncorrected distance visual acuity (UDVA) of 0.88, a UNVA of 5.11 and an MRSE of -0.25D. In the hyperopic ablation group, prior to implantation of the presbyopic IOL the mean corrected distance visual acuity CDVA was 1.05, the mean UNVA was 18.47 and the mean MRSE was +1.05D. Following implantation of the trifocal lens, the mean Snellen UDVA was 0.85, the mean UNVA was 5.25 and the mean MRSE was -0.02D. Luis Brenner MD, Luis.brenner@memira.no
Tags: myopia, presbyopia, trifocals
Latest Articles
Simulators Benefit Surgeons and Patients

Helping young surgeons build confidence and expertise.

Read more...

Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...